Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation

被引:14
|
作者
Walsh, Shawn P. [1 ]
Shahripour, Aurash [1 ]
Tang, Haifeng [1 ]
Teumelsan, Nardos [1 ]
Frie, Jessica [1 ]
Zhu, Yuping [1 ]
Priest, Birgit T. [2 ]
Swensen, Andrew M. [2 ]
Liu, Jessica [2 ]
Margulis, Michael [2 ]
Visconti, Richard [2 ]
Weinglass, Adam [2 ]
Felix, John P. [2 ]
Brochu, Richard M. [2 ]
Bailey, Timothy [2 ]
Thomas-Fowlkes, Brande [2 ]
Alonso-Galicia, Magdalena [3 ]
Zhou, Xiaoyan [3 ]
Pai, Lee-Yuh [3 ]
Corona, Aaron [3 ]
Hampton, Caryn [3 ]
Hernandez, Melba [3 ]
Bentley, Ross [3 ]
Chen, Jing [3 ]
Shah, Kashmira [3 ]
Metzger, Joseph [3 ]
Forrest, Michael [3 ]
Owens, Karen [4 ]
Tong, Vincent [4 ]
Ha, Sookhee [5 ]
Roy, Sophie [3 ]
Kaczorowski, Gregory J. [2 ]
Yang, Lihu [1 ]
Parmee, Emma [1 ]
Garcia, Maria L. [2 ]
Sullivan, Kathleen [3 ]
Pasternak, Alexander [1 ]
机构
[1] Merck Res Labs, Discovery Chem, Kenilworth, NJ 07033 USA
[2] Merck Res Labs, Dept Pharmacol, Kenilworth, NJ 07033 USA
[3] Merck Res Labs, Dept Cardiometab Dis, Kenilworth, NJ 07033 USA
[4] Merck Res Labs, Pharmacokinet Pharmacodynam & Drug Metab, Kenilworth, NJ 07033 USA
[5] Merck Res Labs, Dept Chem Modeling & Informat, Kenilworth, NJ 07033 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 07期
关键词
ROMK; hypertension; heart failure; diuresis; natriuresis; POTASSIUM CHANNEL; BLOOD-PRESSURE; DIURETICS; CLONING; KIR1.1;
D O I
10.1021/ml500440u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new subseries of ROMK inhibitors exemplified by 28 has been developed from the initial screening hit 1. The excellent selectivity for ROMK inhibition over related ion channels and pharmacokinetic properties across preclinical species support further preclinical evaluation of 28 as a new mechanism diuretic. Robust pharmacodynamic effects in both SD rats and dogs have been demonstrated.
引用
收藏
页码:747 / 752
页数:6
相关论文
共 50 条
  • [31] Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
    Kan He
    Joseph M. Luettgen
    Donglu Zhang
    Bing He
    James E. Grace
    Baomin Xin
    Donald J. P. Pinto
    Pancras C. Wong
    Robert M. Knabb
    Patrick Y. S. Lam
    Ruth R. Wexler
    Scott J. Grossman
    European Journal of Drug Metabolism and Pharmacokinetics, 2011, 36 : 129 - 139
  • [32] Discovery and development of Santacruzamate A, a potent and selective histone deacetylase inhibitor
    Balunas, M. J.
    Pavlik, C. M.
    Wong, C. Y. B.
    Lopez, D. D.
    Engene, N.
    McPhail, K.
    Gerwick, W. H.
    PLANTA MEDICA, 2012, 78 (11) : 1050 - 1050
  • [33] Design and Discovery of a Potent and Selective Inhibitor of Integrin αvβ1
    Sabat, Mark
    Carney, Daniel W.
    Hernandez-Torres, Gloria
    Gibson, Tony S.
    Balakrishna, Deepika
    Zou, Hua
    Xu, Rui
    Chen, Chien-Hung
    de Jong, Ron
    Dougan, Douglas R.
    Qin, Ling
    Bigi-Botterill, Simone V.
    Chambers, Alison
    Miura, Joanne
    Johnson, Lucas K.
    Ermolieff, Jacques
    Johns, Deidre
    Selimkhanov, Jangir
    Kwok, Lily
    Dement, Kevin
    Proffitt, Chris
    Vu, Phong
    Lindsey, Erick A.
    Ivetac, Tony
    Jennings, Andy
    Wang, Haixia
    Manam, Padma
    Santos, Cipriano
    Fullenwider, Cody
    Manohar, Rohan
    Flick, Andrew C.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (12) : 10306 - 10320
  • [34] Discovery of IACS-6274: A potent, selective GLS1 inhibitor with excellent pharmacokinetic properties under development for cancers with specific metabolic vulnerabilities
    Soth, Michael
    Le, Kang
    Liu, Gang
    Burke, Jason
    Kovacs, Jeffrey
    Bardenhagen, Jennifer
    Bristow, Christopher
    Czako, Barbara
    Carroll, Chris
    Di Francesco, Maria
    Hamilton, Matthew
    Geck-Do, Mary
    Harris, Angela
    Giuliani, Virginia
    Jiang, Yongying
    Johnson, Troy
    Kang, Zhijun
    Liu, Zhen
    McAfoos, Timothy
    Miller, Meredith
    Palmer, Wylie
    Rogers, Norma
    Shephard, Hannah
    Spencer, Nakia
    Theroff, Jay
    Yau, Anne
    Draetta, Giulio
    Heffernan, Timothy
    Toniatti, Carlo
    Jones, Philip
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [35] Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI)
    Wu, Dongpei
    Pontillo, Joseph
    Ching, Brett
    Hudson, Sarah
    Gao, Yinghong
    Fleck, Beth A.
    Gogas, Kathleen
    Wade, Warren S.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4224 - 4227
  • [36] Translational pharmacokinetic-pharmacodynamic modeling of a potent and selective MEK inhibitor
    Wong, Harvey
    Vernillet, Laurent
    Peterson, Amy
    Ware, Joseph A.
    Lee, Lillian
    Martini, Jean-Francois
    Yu, Peiwen
    Li, Connie
    Del Rosario, Geoffrey
    Prescott, John
    DRUG METABOLISM REVIEWS, 2009, 41 : 163 - 163
  • [37] PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITOR
    Good, S. S.
    Pan-Zhou, X. -R.
    Larsson, M.
    Luo, S.
    Selden, J. R.
    Rashidzadeh, H.
    Bhadresa, S.
    Camire, M.
    Parsy, C.
    Surleraux, D.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S292 - S292
  • [38] Discovery and preclinical evaluation of VRTX126, a novel, highly selective and potent KRASG12Cinhibitor
    Bhavar, Prashant Kashinath
    Surampudi, Uday Kumar
    Sarma, Partha Pratim
    Shidore, Mahesh Mohan
    Kshirsagar, Anuj Ramesh
    CANCER RESEARCH, 2022, 82 (12)
  • [39] Characterization and Preclinical Evaluation of AS-1763, an Oral, Potent and Selective Noncovalent BTK Inhibitor, in Chronic Lymphocytic Leukemia
    Tantawy, Shady I.
    Timofeeva, Natalia
    Fujiwara, Hitomi
    Hatakeyama, Mariko
    Herrera, Breana
    Loza, Lizbeth
    Asami, Tokiko
    Ohmoto, Hiroshi
    Miyamoto, Kyoko
    Nishioka, Yu
    Arimura, Akinori
    Sawa, Masaaki
    Jain, Nitin
    Gandhi, Varsha
    BLOOD, 2023, 142
  • [40] Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution
    Fuerstner, Chantal
    Ackerstaff, Jens
    Meier, Heinrich
    Straub, Alexander
    Mittendorf, Joachim
    Schamberger, Jens
    Schaefer, Martina
    Boerngen, Kirsten
    Joerissen, Hannah
    Zubov, Dmitry
    Zimmermann, Katja
    Tersteegen, Adrian
    Geiss, Volker
    Hartmann, Elke
    Albrecht-Kuepper, Barbara
    D'Orleans-Juste, Pedro
    Lapointe, Catherine
    Vincent, Laurence
    Heitmeier, Stefan
    Tinel, Hanna
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 68 (06) : 6108 - 6126